Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Hungary Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20072
20081
20091
20102
20111
20121
20131
20143
20154
20161
20173
20193
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Novo Nordisk A/S4
Sanofi4
Gan and Lee Pharmaceuticals, USA2
Ixaka Ltd2
Lexicon Pharmaceuticals2
Mylan Inc.2
Andromeda Biotech Ltd.1
AstraZeneca1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 127
Diabetes Mellitus12
Diabetes Mellitus, Type 23
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Insulin Resistance2
Peripheral Arterial Disease2
Autoimmune Diseases1
Diabetic Neuropathies1
Immune System Diseases1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.